AzTrials
AzTrials

Apneic OxygenationRAPIDNCT03694379

Apneic Oxygenation Including Precipitous Intubations During RSI in the ED

A study testing Apneic oxygenation during endotracheal intubation in people with Apneic Oxygenation and Endotracheal Intubation, run by Rutgers, The State University of New Jersey at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This RCT is testing the efficacy of apneic oxygenation during endotracheal intubation in the emergency department. Currently the standard practice in the ED when performing endotracheal intubation is that some providers use apneic oxygenation (the application of a nasal cannula at 15LPM) throughout the intubation… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Apneic Oxygenation, Endotracheal Intubation
What is being tested?
Apneic oxygenation during endotracheal intubation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
1 Mar 2019to 22 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The inclusion criteria for our study will include patients 18 years or older who require emergent endotracheal intubation utilizing rapid sequence intubation (RSI) in the Emergency Department with first attempt taken by a resident or attending physician working in the emergency department. This includes Emergency Medicine attending physicians and residents as well as non-Emergency Medicine rotators (e.g.., Internal Medicine residents who are rotating through the Emergency Department).

Who cannot join

  • Exclusion criteria include patients who are in cardiac arrest, or if the patient received any positive pressure ventilation (i.e, BPAP, CPAP, BVM) in the emergency department before RSI.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University Hospital

    Newark, New Jersey, 07103

Other trials in United States

About this study

Official title: Randomized Controlled Trial of Apneic Oxygenation Including Precipitous Intubations During RSI in the Emergency Department

This RCT is testing the efficacy of apneic oxygenation during endotracheal intubation in the emergency department. Currently the standard practice in the ED when performing endotracheal intubation is that some providers use apneic oxygenation (the application of a nasal cannula at 15LPM) throughout the intubation procedure, while others do not apply apneic oxygenation. Initial literature in the operating room showed that apneic oxygenation helps prevent desaturation during the procedure. However, the latest literature conducted in critical care settings (one study in the ICU and one in the ED) questions the efficacy of this intervention in critically ill patients; however, no harm has been shown. Our study aims to test this intervention further by adding in a special subset of patients that was excluded from prior studies, precipitous intubations, or those patients that have to be intubated quickly and cannot have adequate pre-oxygenation. We hypothesize that apneic oxygenation will be more efficacious in this subset than in the overall ED population. We will randomize patients requiring endotracheal intubation into intervention (apneic oxygenation) and control (no apneic oxygenation). We will measure the lowest arterial oxygen saturation from the start of the intubation procedure through 2 minutes after intubation is complete.

Being tested
Apneic oxygenation during endotracheal intubation
Keywords
Apneic Oxygenation, Endotracheal intubation, Airway Management, Emergency Department
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Apneic oxygenation during endotracheal intubationOther

    Providing oxygenation through nasal cannula during the apneic phase of endotracheal intubation.

Study groups in NCT03694379
Study groupRoleWhat they receive
Apneic OxygenationExperimentalParticipants receiving apneic oxygenation
Receives: Other: Apneic oxygenation during endotracheal intubation
No Apneic OxygenationNo interventionParticipants not receiving apneic oxygenation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lowest oxygen saturation overall

    Lowest oxygen saturation between overall control and intervention groups

    Measured: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation

Secondary outcomes (14)
  1. Lowest oxygen saturation precipitous intubations

    Lowest oxygen saturation between control and intervention groups that did not receive adequate pre-oxygenation only

    Measured: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation

  2. Lowest oxygen saturation pre-oxygenation

    Lowest oxygen saturation between control and intervention groups that did receive

    Measured: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation

  3. Difference in baseline and final oxygen saturation

    Measured: Decision to intubate through 2 minutes after completion of endotracheal intubation

  4. Difference in oxygen saturation before and after apneic period

    Measured: Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation

  5. Desaturation

    The proportion of patients who desaturate below 90%

    Measured: Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation

  6. number of attempts

    number of times laryngoscope is placed into the mouth in an attempt to pass an endotracheal tube

    Measured: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.

  7. Need for second operator

    A second physician had to attempt intubation

    Measured: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.

  8. Need for additional intubating equipment

    The operator needed to change or add equipment to facilitate intubation

    Measured: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.

  9. Esophageal intubations

    The proportion of intubations that resulted in the endotracheal tube being placed in the esophagus

    Measured: From first attempt at intubation through entire ED stay, approximately 6 hours.

  10. Procedural hypotension

    Proportion of became hypotensive at any point during the intubation procedure

    Measured: Initiation of neuromuscular blockade to 2 minutes after completion of endotracheal intubation

  11. Aspiration

    Proportion of patients that had evidence of aspiration

    Measured: Within 24 hours after intubation procedure was complete

  12. Hospital length of stay

    Number of days patient is hospitalized

    Measured: Up to 28 days after intubation

  13. Number of days intubated

    Measured: Up to 28 days after intubation

  14. In-hospital mortality

    Measured: Up to 28 days after intubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2018
  2. Study start1 Mar 2019
  3. Primary completion22 Mar 2020
  4. Study completion22 Mar 2020

Why it stopped: Could not enroll enough patients

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03694379
Sponsor's protocol ID
Pro2018000579
Acronym
RAPID
Status last verified
Mar 2020
First submitted
11 Sep 2018
Last updated
25 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Apneic oxygenation during endotracheal intubation in people with Apneic Oxygenation and Endotracheal Intubation, run by Rutgers, The State University of New Jersey at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 25 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Could not enroll enough patients). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lowest oxygen saturation overall (time frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in